
Overview
Padma Rajagopal is an Oncologist in Baltimore, Maryland. Dr. Rajagopal is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Familial Prostate Cancer, Autoimmune Hemolytic Anemia, and Gastrostomy.
Her clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
Locations
Viragh BLDG 10th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
James Herman is an Oncologist in Baltimore, Maryland. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Johns Hopkins Bayview Medical Center
Josephine (Joy) Feliciano, M.D., is an assistant professor of oncology at The Johns Hopkins University School of Medicine and a faculty member of the Johns Hopkins Kimmel Cancer Center. She serves as medical director of the Thoracic Oncology Program at Johns Hopkins Bayview Medical Center, as well as co-director of the outpatient oncology clinic at Johns Hopkins Bayview. Dr. Feliciano completed both undergraduate and postgraduate medical training at Georgetown University, as well as residency training, where she was selected as chief resident. She spent three years at Northwestern completing clinical training in hematology and oncology, then joined the faculty at University of Maryland Greenberg Cancer Center. At the University of Maryland, Feliciano focused on lung cancer screening and health disparities research for patients with lung cancer. While there, she also earned a certificate degree in the Epidemiology and Human Genetics Program for Clinical Investigation. Dr. Feliciano is also a member of the Miller Coulson Academy of Clinical Excellence. She also serves as the inaugural Medical Director of the Sidney Kimmel Cancer Diagnostic and Treatment Planning Center. Dr. Feliciano is rated as an Elite provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Adrian Murphy is an Oncologist in Baltimore, Maryland. Dr. Murphy is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Familial Colorectal Cancer, Colorectal Cancer, Pancreaticoduodenectomy, and Penectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Rajagopal isAdvanced. Learn about Breast Cancer.
- Experienced
- Autoimmune Hemolytic AnemiaDr. Rajagopal isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Esophageal CancerDr. Rajagopal isExperienced. Learn about Esophageal Cancer.
- Familial Prostate CancerDr. Rajagopal isExperienced. Learn about Familial Prostate Cancer.
- GastrostomyDr. Rajagopal isExperienced. Learn about Gastrostomy.
- Malignant Peripheral Nerve Sheath TumorDr. Rajagopal isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.
- Triple-Negative Breast CancerDr. Rajagopal isExperienced. Learn about Triple-Negative Breast Cancer.
